Cargando…

Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells

Aromatase inhibitor (AI) resistance is a major obstacle in the treatment of estrogen receptor-positive breast cancer. Everolimus (EVE) ameliorates AI-resistant breast cancer and is therefore used in cancer treatment. However, some patients show resistance to EVE. Here, we used 30 clones of long-term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayashi, Takanori, Hikichi, Masahiro, Yukitake, Jun, Wakatsuki, Toru, Nishio, Eiji, Utsumi, Toshiaki, Harada, Nobuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955115/ https://www.ncbi.nlm.nih.gov/pubmed/29805747 http://dx.doi.org/10.18632/oncotarget.25217

Ejemplares similares

Upregulation of CIP2A in estrogen depletion‐resistant breast cancer cells treated with low‐dose everolimus
por: Nishio, Eiji, et al.
Publicado: (2020)

Acquired resistance to everolimus in aromatase inhibitor-resistant breast cancer
por: Kimura, Mariko, et al.
Publicado: (2018)

Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
por: Lui, Asona, et al.
Publicado: (2016)

Lack of association of ovariectomy-induced obesity with overeating and the reduction of physical activities
por: Nishio, Eiji, et al.
Publicado: (2019)

Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years
por: Honma, Naoko, et al.
Publicado: (2009)

Negative progesterone receptor status correlates with increased risk of breast cancer recurrence in luminal B HER2-positive and -negative subtypes
por: Utsumi, Toshiaki, et al.
Publicado: (2021)

Long-term complete remission of metastatic breast cancer, induced by a steroidal aromatase inhibitor after failure of a non-steroidal aromatase inhibitor
por: Shioi, Yoshihiro, et al.
Publicado: (2014)

A Hypoglycemia-inducing Giant Borderline Phyllodes Tumor Secreting High-molecular-weight Insulin-Like Growth Factor II: Immunohistochemistry and a Western Blot Analysis
por: Hikichi, Masahiro, et al.
Publicado: (2017)

Role of aromatase inhibitors in breast cancer
por: Carpenter, R, et al.
Publicado: (2005)

Progress in heterologous biosynthesis of forskolin
por: Ju, Haiyan, et al.
Publicado: (2021)

Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer
por: Higuchi, Toru, et al.
Publicado: (2016)

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience
por: Li, Yi, et al.
Publicado: (2020)

Differences in clinicopathologic features and subtype distribution of invasive breast cancer between women older and younger than 40 years
por: Ushimado, Kaori, et al.
Publicado: (2019)

Inverse correlation between Ki67 expression as a continuous variable and outcomes in luminal HER2-negative breast cancer
por: Ushimado, Kaori, et al.
Publicado: (2019)

Adjuvant Aromatase Inhibitors in Early Breast Cancer May Not Increase the Risk of Falls
por: Choksi, Palak, et al.
Publicado: (2016)

Aromatase inhibitor strategies in metastatic breast cancer
por: McArthur, Heather L, et al.
Publicado: (2010)

Clinical utilities of aromatase inhibitors in breast cancer
por: Chumsri, Saranya
Publicado: (2015)

ARP-1 Regulates the Transcriptional Activity of the Aromatase Gene in the Mouse Brain
por: Honda, Shin-ichiro, et al.
Publicado: (2020)

Tyrosine Kinase Inhibitor Profiling Using Multiple Forskolin-Responsive Reporter Cells
por: Kasahara, Yamato, et al.
Publicado: (2023)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
por: Jayaraman, Swaathi, et al.
Publicado: (2020)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Aromatase inhibitors in advanced breast cancer: there are efficacy differences
por: Bhatnagar, A S
Publicado: (2005)

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
por: Miller, WR
Publicado: (2006)

Forskolin attenuates retinal inflammation in diabetic mice
por: You, Zhi-Peng, et al.
Publicado: (2018)

Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells.
por: Harada, N., et al.
Publicado: (1998)

Behavioral Analysis of Genetically Modified Mice Indicates Essential Roles of Neurosteroidal Estrogen
por: Honda, Shin-Ichiro, et al.
Publicado: (2011)

The combination of forskolin and VPA increases gene expression efficiency to the hypoxia/neuron-specific system
por: Pan, Zhimin, et al.
Publicado: (2020)

Random‐start ovarian stimulation with aromatase inhibitor for fertility preservation in women with Japanese breast cancer
por: Nakasuji, Takashi, et al.
Publicado: (2019)

Simultaneous Quantification of Forskolin and Iso-Forskolin in Coleus forskohlii (Wild.) Briq. and Identification of Elite Chemotype, Collected from Eastern Ghats (India)
por: Shukla, Pushpendra Kumar, et al.
Publicado: (2017)

Salivary Estrogens Androgens and Aromatase Inhibitors by LC-MS/MS in Breast Cancer Patients Treated With Testosterone Pellets Combined With Aromatase Inhibitors
por: Zava, David T, et al.
Publicado: (2021)

Long-term safety of aromatase inhibitors in the treatment of breast cancer
por: Nabholtz, Jean-Marc A
Publicado: (2008)

Molecular response to aromatase inhibitor treatment in primary breast cancer
por: Mackay, Alan, et al.
Publicado: (2007)

Update on the use of aromatase inhibitors in early-stage breast cancer
por: Kesisis, Georgios, et al.
Publicado: (2009)

Characterising an aromatase inhibitor resistant breast cancer cell line
por: Harris, E, et al.
Publicado: (2012)

Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer
por: Haque, Reina, et al.
Publicado: (2012)

Bone Health History in Breast Cancer Patients on Aromatase Inhibitors
por: Kwan, Marilyn L., et al.
Publicado: (2014)

Network-guided prediction of aromatase inhibitor response in breast cancer
por: Ruffalo, Matthew, et al.
Publicado: (2019)

Effects of Acupuncture on Breast Cancer Patients Taking Aromatase Inhibitors
por: Qi, Qing-ling, et al.
Publicado: (2022)

The genomic landscape associated with resistance to aromatase inhibitors in breast cancer
por: Sadasivam, Kirithika, et al.
Publicado: (2023)

Bone loss and the aromatase inhibitors
por: Lester, J, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_4rsuic4tkm01v628uhve2q47na